0.02 
0.00(6.25%) 1:45AM EDT
| Prev Close: | 0.02 |
|---|
| Open: | 0.02 |
|---|
| Bid: | 0.02 |
|---|
| Ask: | 0.02 |
|---|
| 1y Target Est: | 0.02 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.02 - 0.02 |
|---|
| 52wk Range: | 0.02 - 0.03 |
|---|
| Volume: | 645,335 |
|---|
| Avg Vol (3m): | 931,078 |
|---|
| Market Cap: | 14.41M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in AUD.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 25.21 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Jun-11)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | 5.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Avexa Limited, a biotechnology company, engages in the discovery, development, and commercialization of anti-infective pharmaceutical medicines for the treatment of human infectious diseases.
View More